Projects per year
Personal profile
Headline
PROFESSOR Medicine, Rheumatology
Fingerprint
Dive into the research topics where Peter Gorevic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 13 Finished
-
PSYCHIATRIC COMORBIDITY IN CHRONIC FATIGUE SYNDROME
National Center for Research Resources
23/03/07 → 30/11/07
Project: Research
-
PSYCHIATRIC COMORBIDITY IN CHRONIC FATIGUE SYNDROME
National Center for Research Resources
1/12/05 → 30/11/06
Project: Research
-
WHY DO PEOPLE DROP OUT OF SUPPORT GROUPS FOR CHRONIC FATIGUE SYNDROME?
National Center for Research Resources
1/12/03 → 30/11/05
Project: Research
-
PSYCHIATRIC COMORBIDITY IN CHRONIC FATIGUE SYNDROME
National Center for Research Resources
1/12/03 → 30/11/05
Project: Research
-
INTERFERON THERAPY OF CRYOGLOBULINEMIA
National Center for Research Resources
1/10/97 → 30/09/99
Project: Research
-
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
for the NEURO-T. T. R. Open-Label Extension Investigators, Dec 2022, In: Journal of Neurology. 269, 12, p. 6416-6427 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Gorevic, P., Franklin, J., Chen, J., Sajeev, G., Wang, J. C. H. & Lin, H., 2021, In: Expert Opinion on Pharmacotherapy. 22, 1, p. 121-129 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
patisiran Global OLE study group, Jan 2021, In: The Lancet Neurology. 20, 1, p. 49-59 11 p.Research output: Contribution to journal › Article › peer-review
45 Scopus citations -
The enigma of complement activation in mixed cryoglobulinemia
Gorevic, P. D. & Ghebrehiwet, B., Jul 2021, In: Digestive and Liver Disease. 53, 7, p. 858-859 2 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial
Brannagan, T. H., Wang, A. K., Coelho, T., Waddington Cruz, M., Polydefkis, M. J., Dyck, P. J., Plante-Bordeneuve, V., Berk, J. L., Barroso, F., Merlini, G., Conceição, I., Hughes, S. G., Kwoh, J., Jung, S. W., Guthrie, S., Pollock, M., Benson, M. D., Gertz, M., Drachman, B., Gorevic, P., & 13 others, 1 Aug 2020, In: European Journal of Neurology. 27, 8, p. 1374-1381 8 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Scopus citations
Press / Media
-
-
'Consequence and cause': Amyloidosis in the rheumatic diseases
17/08/21
1 item of Media coverage
Press/Media
-
-
Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
2/10/18
1 item of Media coverage
Press/Media